The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome
Open accessAbstract
Hemolytic uremic syndrome (HUS) is a disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Recent studies have identified a factor H-associated form of HUS, caused by gene mutations that cluster in the C-terminal region of the complement regulator factor H. Here we report how three mutations (E1172Stop, R1210C, and R1215G; each of the latter two identified in three independent cases from different, unrelated families) affect protein function. All three mutations cause reduced binding to the central complement component C3b/C3d to heparin, as well as to endothelial cells. These defective features of the mutant factor H proteins explain progression of endothelial cell and microvascular damage in factor H-associated genetic HUS and indicate a protective role of factor H for tissue integrity during thrombus formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
Genetic studies into inherited and sporadic hemolytic uremic syndrome
Warwicker, P., Goodship, T. H. J., Donne, R. L., Pirson, Y., Nicholls, A., Ward, R. M., Turnpenny, P., & Goodship, J. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00824.x · Cited by 497
Richards, A., Buddles, M. R., Donne, R. L., Kaplan, B. S., Kirk, E., Venning, M. C., Tielemans, C. L., Goodship, J. A., & Goodship, T. H. J. (2001) · The American Journal of Human Genetics · doi:10.1086/318203 · Cited by 310
Pérez-Caballero, D., González-Rubio, C., Gallardo, M. E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S., & Sánchez-Corral, P. (2001) · The American Journal of Human Genetics · doi:10.1086/318201 · Cited by 293
CAPRIOLI, J., BETTINAGLIO, P., ZIPFEL, P. F., AMADEI, B., DAINA, E., GAMBA, S., SKERKA, C., MARZILIANO, N., REMUZZI, G., & NORIS, M. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v122297 · Cited by 286
Self-citation(2012) · SpringerReference · doi:10.1007/springerreference_226547 · Cited by 267
Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1
Kühn, S., Skerka, C., & Zipfel, P. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5663 · Cited by 258
Self-citationIdentification of complement regulatory domains in human factor H
Gordon, D. L., Kaufman, R. M., Blackmore, T. K., Kwong, J., & Lublin, D. M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.348 · Cited by 242
Sharma, A. K., & Pangburn, M. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10996 · Cited by 239
Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3b
Jokiranta, T. S., Hellwage, J., Koistinen, V., Zipfel, P. F., & Meri, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002903200 · Cited by 226
Self-citationIdentification of the Second Heparin-Binding Domain in Human Complement Factor H
Blackmore, T. K., Hellwage, J., Sadlon, T. A., Higgs, N., Zipfel, P. F., Ward, H. M., & Gordon, D. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3342 · Cited by 222
Self-citationSánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A. M., Goicoechea, E., López-Trascasa, M., & de Córdoba, S. R. (2002) · The American Journal of Human Genetics · doi:10.1086/344515 · Cited by 218
Fedarko, N. S., Fohr, B., Robey, P. G., Young, M. F., & Fisher, L. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001123200 · Cited by 213
Hypocomplementaemia due to a genetic deficiency of beta 1H globulin.
Thompson, R. A., & Winterborn, M. H. (1981) · PubMed · Cited by 207
Zipfel, P. F., Jokiranta, T. S., Hellwage, J., Koistinen, V., & Meri, S. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00015-6 · Cited by 205
Self-citationThe pathogenesis and treatment of hemolytic uremic syndrome.
Kaplan, B. S., Meyers, K. E., & Schulman, S. L. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961126 · Cited by 203
Hemolytic Uremic Syndrome in Families
Kaplan, B. S., Chesney, R. W., & Drummond, K. N. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505222922102 · Cited by 196
Kühn, S., & Zipfel, P. F. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261017 · Cited by 167
Self-citationAult, B. H., Schmidt, B. Z., Fowler, N. L., Kashtan, C. E., Ahmed, A. E., Vogt, B. A., & Colten, H. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25168 · Cited by 159
Pangburn, M. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4702 · Cited by 133
DiScipio, R. G., Daffern, P. J., Schraufstätter, I. U., & Sriramarao, P. (1998) · PubMed · Cited by 126
Factor H and disease: a complement regulator affects vital body functions
Zipfel, P. F., Hellwage, J., Friese, M. A., Hegasy, G., Jokiranta, S. T., & Meri, S. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00038-3 · Cited by 107
Self-citationProdinger, W. M., Hellwage, J., Spruth, M., Dierich, M. P., & Zipfel, P. F. (1998) · Biochemical Journal · doi:10.1042/bj3310041 · Cited by 100
Self-citationPangburn, M. K., & Mueller-Eberhard, H. J. (1983) · Biochemistry · doi:10.1021/bi00270a026 · Cited by 73
Perkins, S. J., & Goodship, T. H. J. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5337 · Cited by 72
Hindmarsh, E. J., & Marks, R. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6128 · Cited by 70
The Hemolytic-Uremic Syndrome Is a Syndrome
Kaplan, B. S., & Drummond, K. N. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804272981710 · Cited by 70
Devine, D. V., & Rosse, W. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5873 · Cited by 69
Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?
Zipfel, P. F. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01972-x · Cited by 55
Self-citationComplement C3b interactions studied with surface plasmon resonance technique
Jokiranta, T. S., Westin, J., Nilsson, U., Nilsson, B., Hellwage, J., Löfås, S., Gordon, D., Ekdahl, K. N., & Meri, S. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00042-4 · Cited by 53
Self-citationComplement factor H and hemolytic uremic syndrome
Zipfel, P. F., Skerka, C., Caprioli, J., Manuelian, T., Neumann, H. H. P., Noris, M., & Remuzzi, G. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00047-3 · Cited by 33
Self-citation
Research works printed but not linked: 17
- Remuzzi, 1998, Kidney Int. Suppl., 66, S54
- Thompson, 1981, Clin. Exp. Immunol., 46, 110
- 10.1086/302877 · doi:10.1086/302877
- Mathieson, 2002, Lancet., 359, 801, 10.1016/S0140-6736(02)07866-2 · doi:10.1016/s0140-6736(02)07866-2
- 10.1016/S0140-6736(01)06339-5 · doi:10.1016/s0140-6736(01)06339-5
- DiScipio, 1998, J. Immunol., 160, 4057
- Blackmore, 1998, J. Immunol., 160, 3342
- 10.1093/ndt/14.5.1229 · doi:10.1093/ndt/14.5.1229
- Monnens, 1980, Clin. Nephrol., 13, 168
- Noris, 1999, J. Am. Soc. Nephrol., 10, 281, 10.1681/ASN.V102281 · doi:10.1681/asn.v102281
- 10.1111/j.1523-1755.1998.00824.x · doi:10.1111/j.1523-1755.1998.00824.x · Paper page
- 10.1016/0378-1119(95)00360-I · doi:10.1016/0378-1119(95)00360-i
- Gordon, 1995, J. Immunol., 155, 348
- Kuhn, 1995, J. Immunol., 155, 5663
- 10.1093/ndt/13.8.1921 · doi:10.1093/ndt/13.8.1921
- Zoja, 2001, J. Nephrol., 4(Suppl.), S58
- Hindmarsh, 1998, J. Immunol., 160, 6128
Cited by
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Self-citationComplement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
Self-citationComplement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Self-citation
Metadata
- Authors
- Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-04-15
- Volume
- 111
- Issue
- 8
- Pages
- 1181-1190
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1965972308
- Cited by
- 350
- References
- 31
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.